201 related articles for article (PubMed ID: 27091687)
1. Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis.
Stegmiller NP; Barcelos EC; Leal JM; Covre LP; Donatele DM; de Matos Guedes HL; Cunegundes MC; Rodrigues RR; Gomes DC
Vaccine; 2016 Jun; 34(30):3493-9. PubMed ID: 27091687
[TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection.
Hu DL; Omoe K; Narita K; Cui JC; Shinagawa K; Nakane A
Microbes Infect; 2006; 8(14-15):2841-8. PubMed ID: 17090392
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
4. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
[TBL] [Abstract][Full Text] [Related]
5. Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity.
Haghighat S; Siadat SD; Rezayat Sorkhabadi SM; Akhavan Sepahi A; Sadat SM; Yazdi MH; Mahdavi M
Microb Pathog; 2017 Jul; 108():32-39. PubMed ID: 28457901
[TBL] [Abstract][Full Text] [Related]
6. Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus.
Misstear K; McNeela EA; Murphy AG; Geoghegan JA; O'Keeffe KM; Fox J; Chan K; Heuking S; Collin N; Foster TJ; McLoughlin RM; Lavelle EC
J Infect Dis; 2014 May; 209(9):1479-84. PubMed ID: 24273045
[TBL] [Abstract][Full Text] [Related]
7. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.
Kuklin NA; Clark DJ; Secore S; Cook J; Cope LD; McNeely T; Noble L; Brown MJ; Zorman JK; Wang XM; Pancari G; Fan H; Isett K; Burgess B; Bryan J; Brownlow M; George H; Meinz M; Liddell ME; Kelly R; Schultz L; Montgomery D; Onishi J; Losada M; Martin M; Ebert T; Tan CY; Schofield TL; Nagy E; Meineke A; Joyce JG; Kurtz MB; Caulfield MJ; Jansen KU; McClements W; Anderson AS
Infect Immun; 2006 Apr; 74(4):2215-23. PubMed ID: 16552052
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
Aqib AI; Anjum AA; Ijaz M; Hussain R; Ahmed R; Farooqi SH; Aslam HB; Hussain K; Mehmood K; Zhang H
Microb Pathog; 2018 Apr; 117():341-347. PubMed ID: 29510207
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Staphylococcal Antigen-F (r-ScaF), a novel vaccine candidate against methicillin resistant Staphylococcus aureus infection: Potency and efficacy studies.
Majelan PA; Mahdavi M; Yazdi MH; Salimi E; Pourmand MR
Microb Pathog; 2019 Feb; 127():159-165. PubMed ID: 30521844
[TBL] [Abstract][Full Text] [Related]
10. IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.
Narita K; Asano K; Nakane A
Med Microbiol Immunol; 2017 Jun; 206(3):225-234. PubMed ID: 28378247
[TBL] [Abstract][Full Text] [Related]
11. Global antibody response to Staphylococcus aureus live-cell vaccination.
Selle M; Hertlein T; Oesterreich B; Klemm T; Kloppot P; Müller E; Ehricht R; Stentzel S; Bröker BM; Engelmann S; Ohlsen K
Sci Rep; 2016 Apr; 6():24754. PubMed ID: 27103319
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
[TBL] [Abstract][Full Text] [Related]
13. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
14. Cross-protective effect of a novel multi-antigen-chimeric vaccine against Streptococcus and Staphylococcus aureus infection in mice.
Yu L; Fan Z; Ma J; Tong C; Song B; Zhu Z; Cui Y
J Med Microbiol; 2014 Dec; 63(Pt 12):1732-1740. PubMed ID: 25288644
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus.
Chan JYH; Clow F; Pearson V; Langley RJ; Fraser JD; Radcliff FJ
Immunol Cell Biol; 2024; 102(5):365-380. PubMed ID: 38572664
[TBL] [Abstract][Full Text] [Related]
16. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK
PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035
[TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of Hla-MntC-SACOL0723 fusion protein adjuvanted in alum and MPL against Staphylococcus aureus sepsis infection in mice.
Ghaedi T; Davoodian P; Hassaniazad M; Eftekhar E; Faezi S; Abparvar AA; Einakian MA; Ahmadi K
J Immunol Methods; 2021 Jul; 494():113055. PubMed ID: 33857474
[TBL] [Abstract][Full Text] [Related]
18. Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B ( N 126- P 361) -target of RNAIII activating protein in mice.
Yu L; Wang N; Ma J; Tong C; Song B; Chi J; Ma G; Zhu Z; Cui Y
Microbiol Immunol; 2013 Dec; 57(12):857-64. PubMed ID: 24117875
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
Adhikari RP; Thompson CD; Aman MJ; Lee JC
Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus avirulent mutant vaccine induces humoral and cellular immune responses on pregnant heifers.
Pellegrino M; Rodriguez N; Vivas A; Giraudo J; Bogni C
Vaccine; 2016 Jun; 34(29):3356-62. PubMed ID: 27195762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
